Hennion & Walsh Asset Management, Inc. Catalent, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$53.58 - $57.02 $37,559 - $39,971	-701 Reduced 7.4%	8,766 $492,000
Q1 2024 Apr 17, 2024	SELL	$42.56 - $59.82 $305,112 - $428,849	-7,169 Reduced 43.09%	9,467 $534,000
Q4 2023 Jan 10, 2024	SELL	$32.18 - $46.57 $25,679 - $37,162	-798 Reduced 4.58%	16,636 $747,000
Q3 2023 Oct 27, 2023	SELL	$44.2 - $50.2 $494,951 - $562,139	-11,198 Reduced 39.11%	17,434 $793,000
Q2 2023 Aug 09, 2023	SELL	$31.86 - $67.26 $48,522 - $102,436	-1,523 Reduced 5.05%	28,632 $1.24 Million
Q1 2023 Apr 20, 2023	SELL	$45.44 - $74.26 $321,260 - $525,018	-7,070 Reduced 18.99%	30,155 $1.98 Million
Q4 2022 Jan 12, 2023	SELL	$41.39 - $81.0 $35,388 - $69,255	-855 Reduced 2.25%	37,225 $1.68 Million
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $327,284 - $511,551	-4,523 Reduced 10.62%	38,080 $2.76 Million
Q2 2022 Jul 19, 2022	BUY	$87.2 - $114.05 $17,440 - $22,810	200 Added 0.47%	42,603 $4.57 Million
Q1 2022 Apr 26, 2022	BUY	$94.19 - $124.49 $698,795 - $923,591	7,419 Added 21.21%	42,403 $4.7 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $538,782 - $626,649	4,506 Added 14.78%	34,984 $4.48 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $954,036 - $1.24 Million	8,739 Added 40.2%	30,478 $4.06 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $213,423 - $246,072	2,127 Added 10.85%	21,739 $2.35 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $1.99 Million - $2.46 Million	19,612 New	19,612 $2.07 Million

319

114M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.